Gain greater knowledge of topics of broader interest, beyond what is covered in the other categories.
This course assumes that you want to dive deeper into the knowledge of the tools used to harness big data (beyond spreadsheets). A course designed to allow you to develop robust practices when working with large datasets. It will offer you powerful options for data analysis and is designed to help increase your productivity. This interactive and hands-on course will introduce you to R and advanced scripting to manage data with Linux™ .
Who should attend − This course is open to anybody dealing with large datasets, not just Ion Torrent™ users. Data scientists and biologists who want to understand their local bioinformatician language and explore what can be done with their data with an interest to go beyond the graphic interface should enjoy this course. Explore the open source world associated to bioinformatics with our experienced professionals.
At the end of this training, you will receive a virtual machine with the scripts and examples produced during the week so you can immediately apply what you have learned.
Prerequisites — It is recommended that participants in this training have attended our introductory course Bioinformatics for Molecular Biologists or have corresponding knowledge of Linux and shell scripting.
Course fee includes — Course materials and lunch. Travel and other incidental expenses relating to the training are the responsibility of the attendee.
Cancellation policy — Thermo Fisher Scientific reserves the right to cancel or reschedule a course up to 10 working days prior to the listed course start date. For more information, please refer to the Terms and Conditions below.
For Research Use Only . Not for use in diagnostic procedures.


text:
Add java_opts params to tomcat::instance for setting JAVA_OPTS on RedHat7 only for the moment (deprecating $setenv)

## 2015-09-17 - Release 0.14.2

Fix: Service resource sometimes refresh before Exec systemd reload

## 2015-09-15 - Release 0.14.1

Fix for RHEL 7
Add Ubuntu 14.04 support
Fix acceptance tests

## 2015-08-21 - Release 0.14.0

Prevent puppet restarting tomcat when it shouldn't
Install make to build ruby-augeas

## 2015-08-21 - Release 0.13.9

Use docker for acceptance tests

## 2015-06-30 - Release 0.13.8

Fix unit tests

## 2015-06-26 - Release 0.13.7

Fix strict_variables activation with rspec-puppet 2.2

## 2015-05-28 - Release 0.13.6

Add beaker_spec_helper to Gemfile

## 2015-05-27 - Release 0.13.5

Fix unscoped variable in template

## 2015-05-26 - Release 0.13.4

Use random application order in nodeset

## 2015-05-26 - Release 0.13.3

add utopic & vivid nodesets

## 2015-05-25 - Release 0.13.2

Don't allow failure on Puppet 4

## 2015-05-19 - Release 0.13.1

Fix when using a server_xml_file

## 2015-05-19 - Release 0.13.0

Use puppetlabs-concat instead of theforeman-concat_native

## 2015-05-18 - Release 0.12.0

Add dynamic dependency between install and service

## 2015-05-15 - Release 0.11.2

Fix missing ownerships
Internal refactoring

## 2015-05-13 - Release 0.11.1

Add puppet-lint-file_source_rights-check gem

## 2015-05-13 - Release 0.11.0

Remove experimental implementation

## 2015-05-12 - Release 0.10.5

Don't pin beaker

## 2015-04-27 - Release 0.10.4

Add nodeset ubuntu-12.04-x86_64-openstack

## 2015-04-15 - Release 0.10.3

Use file() function instead of fileserver (much faster)
Fix for concat_native 1.4+
Requires concat_native 1.4+

## 2015-04-14 - Release 0.10.2

add a parameter catalina_base_mode that sets rights on catalina_base

## 2015-04-10 - Release 0.10.1

Fix init script when overriding JAVA_HOME in setenv-local.sh

## 2015-04-03 - Release 0.10.0

Add Debian 8 support
Add acceptance tests for debian6 and centos6 to travis matrix
Remove RedHat 5 support (may still work but untested)

## 2015-03-24 - Release 0.9.0

Support Debian Jessie (with tomcat7)
Add acceptance tests on Travis CI

## 2015-03-24 - Release 0.8.10

Update Gemfile

## 2015-03-13 - Release 0.8.9

Fix a bug with systemd service file

## 2015-03-11 - Release 0.8.8

Fix: Tomcat::Connector should refresh Service

## 2015-02-19 - Release 0.8.7

Fix for future parser

## 2015-02-18 - Release 0.8.6

Revert fix

## 2015-02-18 - Release 0.8.5

Fix future parser issue

## 2015-01-29 - Release 0.8.4

Don't use fakeroot for unit tests
Fix future parser issues
Use absolute names in class inclusions
Use undef instead of empty strings

## 2015-01-07 - Release 0.8.3

Fix unquoted strings in cases

## 2015-01-05 - Release 0.8.2

Add CHANGELOG.md
Fix license name in metadata.json
Simplify bundler cache in Travis CI

redpajama_set_name: RedPajamaGithub


text:
Envisioning a society where people's diversity is valued, liberties are respected, and rights are lived.
Our Vision The Manitoba Association for Rights and Liberties envisions a society where diversity is valued, liberties are respected, and rights are lived.
Land Acknowledgement The MARL is located on the traditional territory of the Anishinaabe, Cree, Oji-Cree, Dakota, Dene and Metis peoples.
Our History Incorporated in 1978, the MARL has worked to promote and defend rights in Manitoba in many different capacities.
Our Team MARL works with a small team of dedicated staff and volunteers. Find out more about the people behind our organization.
Board Members Meet the board members of MARL
Committees MARL works with volunteers of many skills and professions. If you are interested in joining a volunteer committee, contact us for more information.
Supporters A big thank you to our supporting partners!
Practicum Students MARL offer Under-graduate and Graduate students to experience working in a Non-profit sector while pursuing their Degree.
Volunteer Join our team of engaged volunteers.
Newsletter Sign up to our newsletter to get the latest news and updates.
Donate Support human rights education in Manitoba now!

redpajama_set_name: RedPajamaCommonCrawl


« Fall Kickoff: What Can Your Church Do Better?
Plan and plan and plan some more.
Create a consistent look and feel.
Get everyone is on board or no one is.
Learn more about how to make that happen with our free Communicating Fall Without Creating Noise resource.
This is one of our Courageous Storytellers member resources that we've decided to share with you. It's a taste of the kind of practical, helpful resources we put out every month for our members.
We're focusing on fall kickoff this month, and that's just one of the many resources. Go ahead and check out the full offering.
It's a serious value. Learn more about Courageous Storytellers and consider becoming a member today.
Meiko Seymour is the author of The Heartbeat System, a community life pastor at Pinellas Community Church in St. Petersburg, Fla., and an avid fan of coffee. Meiko blogs over at meikoseymour.com where his passions are to move people forward toward their goals and dreams as they work to contribute to our society.
Read more posts by Meiko Seymour | Want to write for us?


A lot of gear comes with extended zipper pulls. Our experience is they usually fail and break off, aren't velcro friendly and don't have reflective qualities.
Get ready to retrofit your gear with the most advanced zipper pulls on the market today. We build them right here in Seattle using top grade hi-test reflective nylon cord and grooved pull tabs for better gripping. They can be retrofitted to zippers on luggage, boots, jackets, pants, vents, tents, sleeping bags and anything else you can dream of. And because they use reflective cord you'll be able to spot things easy in the dark.
Beyond your motorcycle gear, consider these for a great way to identify your luggage when it comes down the carousel at the airport.
Installation is easy using our simple to follow instructions and can be done in seconds with no special tools required.
If it has a zipper, make it easier to find and get at with our exclusive Sound RIDER! Hi-Viz Zip E-Zs.
Available in the four colors shown - black, orange, yellow and blue. Select from packs of 5, 12 and 25 per color.
NEW - Get a hold of our 24 piece combo set (shown at left) that includes an assortment of 12 black, 4 orange, 4 yellow and 4 blue Zip E-Zs.
Tip - Use bright colors for primary zippers and dark for lesser used zippers. This is really handy on tank bags and tail packs where multiple zippers are near one another.


The days have passed when you had to pay for a space in the local newspapers or the yellow pages in order to make your business known to potential customers. Today, the internet has changed business marketing, and web presence marketing is the rule of the game. Business owners from different parts of the world are trying to make sure that their businesses are easily found online. It is worth noting that web marketing is now one of the most effective ways that local Las Vegas business owners are using to reach their potential customers and stay ahead of their competitors. The following are the five basic reasons why you should market your Las Vegas business online.
With the rapid rise of web presence marketing, you can make your business more visible to potential customers by marketing it online. It is viable to note that many consumers in Las Vegas and other parts of the world today use the internet to search for the products that they want to buy. This means that web marketing Las Vegas consumers can easily find your business.
By creating a website for your business, you expose your business not only to customers within the area where your business is located but also to the rest of the world. This means that although your business is in Las Vegas, web presence marketing can get you customers and awareness globally.
It is not possible to attend to all the needs of your clients on a timely basis using conventional customer support methods. However, with web marketing Las Vegas you have an active website for your business where consumers can visit and find all the information they want about your products.
Potential customers are more attracted to businesses that have attractive and professional websites. Your business might be a small one, but a good website could give it a bigger reputation to potential customers. Proper Las Vegas marketing, therefore, enables you to be ahead of competitors because consumers who cannot find the physical place of your business will easily find you online.
Another benefit associated with web presence marketing is the fact it enables you to improve credibility of your business. Web marketing Las Vegas enables you to improve reputation of your business by adding influential stakeholders in your business website. These could include potential investors, employees and your satisfied customers.
Web marketing for your Las Vegas business needs the right strategy and the right crew. Launch your web presence today.


text:
The 2016 Volta ao Algarve was a road cycling stage race that took place in the Algarve region of Portugal between 17 and 21 February 2016. It was the 42nd edition of the Volta ao Algarve and was rated as a 2.1 event as part of the UCI Europe Tour.

The race was won by defending champion, 's Geraint Thomas.

The race consisted of five stages. Two of these were summit finishes, while the third was an individual time trial.

Teams

The race organisers invited 24 teams to start the race. Twelve of these were UCI WorldTeams; four were UCI Professional Continental teams; eight were UCI Continental teams. Each team could include up to eight riders.

Route

The race includes five stages. The first stage is moderately hilly, with a flat finish. It is followed by a summit finish on the second stage, with the climb of the Alto da Foía, the highest point in the region. The climb has not been used in the Volta ao Algarve since 2002. There is then a flat,  individual time trial on the third stage. Another moderately hilly stage follows on the fourth stage. The fifth and final stage ends with the climb of the Alto do Malhaõ, traditionally the decisive point in the race.

Classifications

References

External links

Volta ao Algarve
Volta ao Algarve
2016

redpajama_set_name: RedPajamaWikipedia


text:
Q: Is it possible to install "Windows Phone 7 developer tools" on "Windows 7 Starter edition" and run the WP7 emulator? Is it possible to install "Windows Phone 7 developer tools" on "Windows 7 Starter"?
Does the WP7 emulator run after install?
I have a old laptop Sony Vaio which has been upgrade into W7 Ultimate and VS2010 pro, but the graphic card is too old and WP7 emulator won't run.
Can anyone have try to run the WP7 emulator on a Win7 Starter edition?

A: I'm afraid the tools are not supported on Windows 7 starter edition.
From the download page:

System requirements
  Supported Operating Systems: Windows 7, Windows Vista
•Windows® Vista® (x86 and x64) with Service Pack 2 – all editions
  except Starter Edition.
•Windows® 7 (x86 and x64) – all editions
  except Starter Edition.

You might get VS to run, but I think you'll hit problems with the emulator as it runs in a VM, which Windows 7 Starter won't support.

A: I can't comment on using Windows 7 starter edition, however if the machine you are planning on using is an Intel Atom based netbook I think you may find that you struggle to run Visual Studio and the WP7 Device Emulator simultaneously.
I was certainly unable to the last time I tried on an Atom based machine, even with 3GB of RAM.

redpajama_set_name: RedPajamaStackExchange


text:
Q: Reference request for a theorem in Lee's Smooth Manifolds In Lee's book Introduction to Smooth Manifolds, he remarks on page 25 that

It is a fact (which we will neither prove nor use) that $F: U\rightarrow \mathbb R^k$ is smooth in this sense if and only if $F$ is continuous, $F|_{U\cap \text{Int }\mathbb H^n}$ is smooth, and the partial derivatives of $F|_{U\cap \text{Int }\mathbb H^n}$ of all orders have continuous extensions to all of $U$.

This follows a discussion of the definition of a smooth function on an arbitrary subset of $\mathbb R^n$. A function on such a set is defined to be smooth if and only if it admits a smooth extension to an open neighborhood of each point. The quote concerns functions defined on the closed upper half space (the subset of $\mathbb R^n$ with $x_n \ge 0$).
My question: Where can I find a proof of the quoted theorem?

A: Good question.  One direction is immediate; the other direction depends on a lemma of Émile Borel, which shows that there is a smooth function defined in the lower half-space whose derivatives all match those of $F$ on $U \smallsetminus \mathbb H^n$. See, e.g., Theorem 1.2.6 in The Analysis of Linear Partial Differential Operators I: Distribution  Theory and Fourier Analysis, 2nd ed., by Lars Hörmander. (I included this reference in the second edition of my Smooth Manifolds book.)


text:
Top 12 Editor Picks
gina haspel
On Twitter, Donald Trump Announces Mike Pompeo as Secretary of State; Rex Tillerson Out
JOSEPH EID,JIM WATSON/AFP/Getty Images
by Charlie Spiering13 Mar 20180
President Donald Trump announced that CIA director Mike Pompeo would be the new Secretary of State, replacing former Exxon-Mobil CEO Rex Tillerson.
"Mike Pompeo, Director of the CIA, will become our new Secretary of State. He will do a fantastic job!" Trump wrote on Twitter. "Thank you to Rex Tillerson for his service!"
Pompeo has earned Trump's trust as Director of the CIA and has been rumored to replace Tillerson for some time.
"I have gotten to know Mike very well over the past 14 months, and I am confident he is the right person for the job at this critical juncture," Trump said in a statement issued by the White House. "He will continue our program of restoring America's standing in the world, strengthening our alliances, confronting our adversaries, and seeking the denuclearization of the Korean Peninsula."
Trump's decision was sudden, as Tillerson does not appear to know why he was fired.
"The Secretary had every intention of staying because of the critical progress made in national security," Under Secretary of State Steve Goldstein said in a statement. "The Secretary did not speak to the President and is unaware of the reason, but he is grateful for the opportunity to serve, and still believes strongly that public service is a noble calling."
Tillerson just returned from a trip abroad to Chad and Nigeria, before cutting his trip short to refocus on North Korea.
Trump's surprise announcement took place less than four hours after Tillerson's flight landed.
"I want to thank Rex Tillerson for his service," Trump said briefly in a statement. "A great deal has been accomplished over the last fourteen months, and I wish him and his family well."
The White House said that Trump wanted a fresh approach to his administration's diplomatic efforts, and wanted to have his team in place in time for negotiations with North Korea.
Trump also announced that Deputy Director of the CIA Gina Haspel take Pompeo's place as Director of the CIA, the first woman to be appointed to the job.
Previous articleTrump ousts Rex Tillerson as U.S. secretary of state
Next articleE.ON not striving to be a 'national champion,' says CEO after major German energy deal
Over $60 billion wiped off value of cryptocurrencies as bitcoin slide continues
Europe's third-largest insurer posts record high operating profit for 2017
China is ready for a trade war with the US — and it could hurt Americans
US solar industry installed over 10 gigawatts of new capacity in 2017, report says
Citi launches a Facebook Messenger 'chatbot'
Warren Buffett sees 'substantial' investment gains, knocks fund managers
Warren Buffett's Berkshire Hathaway released its closely-watched annual letter on Saturday, in which the Oracle of Omaha told investors that...
Asia set to open higher as investors await key speech from President Trump
Here's what happened to Manson cult followers who murdered Sharon Tate, 5 others
/FOX NEWS/US
Contact us: editor@GLA.News
© Copyright 2017 | www.gla.news


And the deeper level (where you know the thing by which you know) Never settle for appearances until you are "awake" enough to realize that that is all there is. Thoughts say "how they feel" and men who say "how they feel" have no feel for thoughts.
Reads: Every trick I discovered to help me keep awake both helped me and hindered me. It would for the moment help keep me awake but did, over the long haul, hinder me, by causing me to imagine that I was getting somewhere.
The ultimate in escape tricks is getting out of the illusionary straight jacket called "Am I making progress?" The more you accept your verbalized "feelings" to be real feelings, the less you will ever realize about the reality of your thinking.
05:00 Reads: To be insultable (made up word) is to get insulted. Concerning direction of sight and another certain matter - you cannot look back and not have "feelings." Whenever you write/say/think the word "feeling" it should be put in quotation marks.
A lad said to his Father; "What are we other than what we think we are?" To which the Father responded; Everything that doesn't think about what you are. "And the lad later concluded, "You could never know what you are." Which somehow came as a notable relief, for a while.
People take being who/what they think they are far too seriously. What you actually are is not at all a serious matter. Instinct does not take itself seriously, only thoughts do.
10:00 The more attention is held by the sensation of who/what you are - the less notice you give to the nature of the mind. If you live by "how you feel" being "asleep/distracted" won't bother you.
15:00 Living "by how you feel" puts you in line with six billion complaining people. And more than likely you would not be sitting here.
"How you feel" is what you talked about in high school. The short range skirmishes, being frightened by a bully to long range skirmishes/parents. But if "how you feel" had been sufficient you could have saved yourself from all of this.
20:00 Refer back to the two layers of the mind. When talking about the deeper level I am not referring to psychological version of sub consciousness. The subconscious is subcortical activity of the nervous system. It is not the mind/consciousness.
25:00 Most everyone on the planet has a lifetime of being insulted. To be "insultable" is to be insulted. I am not referring to behavior. If you still fume or cry over being insulted I am astounded you are still here.
What I refer to is the belief that thoughts in your head can be changed. Which keeps you involved with busy work. People believe being insulted is an anomaly and want to talk about it. From one cold blooded view, it is childish. Its like taking another breath.
30:00 Are the thoughts you "feel" a "true representation" of reality? The general point is that ordinary people do not see being "insultable" as a natural state. I find it interesting an everyday occurrence, "insultable" is not in our dictionaries.
You cannot reminisce and not have feelings. Can you reminisce impartially? Some of you looked off for a minute so I will answer it. You can't.
40:00 If you want to continue to be trapped in the illusion of "how you feel" keep entertaining thought's "feelings" about the past.
45:00 A boy said to his father, "What are we other than what we think we are?" And the father said, "Everything that does not think about what you are." In other words what is there besides what we think we are?
And the answer is "Everything that doesn't think about what you are. " A direct answer that can't be talked about/discussed. Never knowing can be a great relief.


Wedding planning entails a number of emotions, from excitement and fun to a bit of stress thrown into the mix. By the time you're ready to walk down the aisle, you want your skin looking as flawless as possible!
Like many other aspects of wedding planning, your skin care regimen should be started enough in advance of the wedding date to give you time to address your concerns, whether that means combating fine lines and wrinkles, brightening up your skin's overall appearance or reducing dry patches or discoloration.
Skin care experts have provided a number of tips to ensure you have perfect skin come wedding time; the best rule of thumb is to start as soon as you set a wedding date! Dermatologists suggest following a month-to-month guide in order to give yourself plenty of time to treat and maintain a healthy skin care routine.
As soon as you set your wedding date, or, if it's far enough in the future, give yourself at least 12 months, book an appointment to see a dermatologist. Go over any of your concerns with your doctor, including signs of aging or acne or tell her you simply want to rejuvenate the skin to create a healthy glow for your wedding day. Apply sunscreen to the skin daily, even in winter, to protect it against unusual tan lines or sun damage. This is especially important if you plan to wear a strapless or sleeveless gown.
Continue to follow up with your dermatologist and make any adjustments needed for your skin care routine. Consistency is key when using skin care products, and straying from a routine could actually create more issues for the skin. Keep in mind that time is needed to achieve and see results. Dermatologists also warn that breakouts at the start of a skin care routine are common and will clear up naturally, another reason you want to start well in advance of your wedding day! Dermatologists also suggest drinking plenty of water and getting exercise to reduce stress and remove toxins from the body as you get deeper into wedding planning.
Continue to check in with your dermatologist and maintain consistent skin care as directed. Begin additional skin care treatments such as body polishing–exfoliating with sugar or salt scrubs–to remove dry skin and reveal a healthier, smoother complexion. If you need to spray tan, this is an ideal time to experiment with shades and application techniques to narrow down the best options for your wedding day.
Schedule your makeup application and determine which colors or products you want to use for your skin. Brightening products and Vitamin C serums may also be used to enhance a natural glow. Dermatologists recommended adding a skin care budget into the overall wedding beauty budget to ensure you have enough to cover your products and skin appointments.
Take special care to make sure your skin is as smooth and bright as possible. Gentle exfoliation or doctor-supervised skin peels should be done one to two weeks before the wedding to allow time for redness to subside. Avoid direct sunlight after exfoliation or chemical peels, as the skin will be more sensitive and prone to burning. Make sure you get at least eight hours of sleep and drink plenty of water!
Give your skin that final boost of hydration with a mask. A hydrating, cooling gel mask is ideal to reduce any puffiness around the eyes and face!
For any bride, a number of skin care treatments are effective and help facilitate a bright and smooth appearance. Exfoliation is key to remove dead skin cells from the skin's surface; your skin will look and feel healthier and it helps skin care products soak in more readily and work properly.
Every bride–indeed, every woman–stands to benefit from exfoliation. A variety of factors increase the accumulation of dead skin cells, including weather and seasons, pollution levels, sun exposure and even the skin care products used.
Additionally, dermatologists suggest those with sensitive skin experience increased benefits through exfoliation.
Exfoliation helps combat numerous skin conditions, including discoloration, clogged pores and premature aging. Removing dry skin cells from the face and brightening up the appearance also improves the look and feel of wedding day makeup. It allows products to go on smoother and reduces the risk of foundation or powder caking up in fine lines and wrinkles.
Sources: ADVdermatology.com, thedermatologyclinic.com and vogue.com.


text:
Outsourcing in Clinical Trials East Coast 2021 - Virtual Conference
25th-26th May, 2021
Outsourcing in Clinical Trials East Coast 2021 has a new date! We are pleased to announce that we will be going ahead on our brand new online event platform on our new dates of 25-26 May 2021!
Discover effective strategies for outsourcing clinical trial operations to ensure studies run smoothly and within budget.
Arena International are delighted to announce Outsourcing in Clinical Trials East Coast will be returning for its 11th Annual event!
The 2021 programme will feature a range of speakers from the likes of GlaxoSmithKline, Novartis, Pfizer, BMS any many more, who through a variety of interactive session formats will offer insight on promoting successful collaboration between the clinical trials community. Attendees will have the opportunity of taking part in sessions across 3 stages, each focusing on a different topic area. Whether your role is Clinical Operations, Technology & Innovation or Clinical Data Management this event can not be missed
Register sponsor agenda
A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES RIGHT AT A TAP OR CLICK OF A BUTTON
Simply register, login on the day and get ready to connect and learn. With the right network at your fingertips, learning and connecting have never been so easy.
https://arena-international.com/wp-content/uploads/2019/05/Global-Data-Events-Platform-User-Demo.mp4
💻 Watch live and recorded thought leadership presentations
🗣 Take part in live Q&A with industry experts from across the globe
👩💻 One-to-one & group video chat with each solution provider
🤝 Chat & network with anyone on the platform
📊 Take part in our interactive polls
👥 Join live panel debates and discussions
🛍 Download resources from solution providers to your event bag
OCT East Coast providers an exceptional networking opportunity for the local Philadelphia biopharma industry, giving attendees the chance to re-discover connections and make new contacts across the region
OCT East Coast has a focus on interactivity; moving away from stale presentation, this event offers all attendees the chance to join the conversation and have their voice heard
The exhibition will showcase 50 of the best in business vendors for clinical trials, whatever your need OCT East Coast will have the answer
Susan Lubin
Director Clinical Pharmacology and Oncology Operations
Ram Raju
Senior Vice President and Community Health Investment Officer, Northwell Health
Jigna Parekh
Senior Clinical Trial Manager
Incyte
Behtash Bahador
Associate Director Relationship Management and Development
CISCRP
Cathleen Platt
Head of Clinical Operations
Click Therapeutics
Sameer Tandon
Digital Strategy Lead, Clinical Trial Innovation
Ratan Ratnesh
Director of Clinical Outsourcing
Lynnette Etzel
Associate Director, Relationship Manager
Director Clinical Pharmacology and Oncology Operations,Bristol Myers Squibb
Susan has 20+ years of experience working in the early development space with Bristol-Myers Squibb
She is a RN with a Masters Degree in Health Care Administration
Has held a variety of roles such as Administrator of BMS Phase 1 Clinic, Outsourcing Manager and recently is the Director of Clinical Pharmacology and Oncology Operations
Session Details: Is the Full Service Approach the Best Outsourcing Model When Working with Tight Timelines and Budgets? Exploring the Options to Help us Come to the Best Decision 25-05-2021, 12:15 pm View In Agenda
Senior Vice President and Community Health Investment Officer, Northwell Health,
Biography: 100 Most Influential Leaders in Healthcare 2014, 2015 & 2016 50 Most Influential Physicians Leaders and Executives 2013,2014,2015 & 2016 Top 25 Minority Healthcare Executives in Nation 2012,2014 &2016 Chicago United's Business Leaders of Color for 2013. Who is Who in Chicago Chicago's Most Influential People- Crain's Business 2012 & 2013 Becker's Top Physician Executives 2013 &2014 Becker's 20 Hospital and Health System Leaders to Follow on Twitter Hispanic Health Leadership Award National Hispanic Health Foundation Community Service Award Touro College 2015 Healthcare Visionary award Comunilife 26th anniversary Breakfast 2015 Distinguished Leader of Indian Origin AAPIQLI Gala 2015 Excellence in Health services Award; Concerned Women of Brooklyn Crown Heights Jewish Community Council Humanitarian Award 2016 National Minority Quality Forum: Booker T Washington Award (for promoting Diversity at all levels and reduce healthcare disparities at a national level) 2016 Wheel Chair Charities: Health Care Visionary Award 2016 Primary Care Development Corporation Leadership award 2016 CRAIN 100- 100 Innovators, Disruptors and Change-Makers in Business 2016 South Asian Council for Social Services SACSS; Award in recognition of service to immigrant communities Community Award- Russian American Foundation 2010 Humanitarian award- Metropolitan Auxiliary 2011 Standing on our Fathers Shoulders- Congressional Citation 2012 Healing Hands Award – Chicago Family Health Center 2013 Doctorate of Humane Letters- NY College of Podiatric Medicine 2014 NYC Public Advocate's Award for Public Service 2014 Tamil Ratna US Tamil Sangam 2014 Leadership and Service Award TANA 2015 Justice and Opportunity Award NY Immigration Coalition `2015 Leadership Award Indian Association of Long Island 2015 Tamil Pioneer Award Federation of Tamil Sangams USA 2015 Professional Achievement Award- Medical Society of the County of Kings
Session Details: PANEL DISCUSSION - Studying the Importance of Getting A Diverse Patient Group Onto Your Study 25-05-2021, 4:00 pm View In Agenda
Senior Clinical Trial Manager,Incyte
Biography: Jigna Parekh is a registered Pharmacist with a degree in PharmD and MS in Pharmacology & Toxicology. Dr. Parekh has over 12 years of experience working in clinical research with extensive knowledge of phase I, II, III, extension clinical trials (in-patient and out-patient studies). She has managed diversified global clinical trials that are in-house based, consortium, fully outsourced and partially outsourced in various therapeutic areas such as Rare disease indications, Oncology (adult and pediatric), CVS, CNS, Respiratory (adult and adolescent) and Diabetes. She has experience working for both CRO & Sponsor in clinical trial conduct and presents strong leadership, decision-making and problem-solving skills. Dr. Parekh joined Incyte not very long ago as a Senior Clinical Trial Manager and is very excited to join the team. She is currently managing rare disease clinical trials at the Incyte's Inflammation & AutoImmunity (IAI) group. In addition, Dr. Parekh interacts with media with regards to clinical trial processes, presenter at the Clinical trial conferences. She also has paper publications and a peer-reviewer of scientific journals.
Session Details: Speaker Hosted Roundtables 26-05-2021, 3:30 pm View In Agenda
Associate Director Relationship Management and Development,CISCRP
Biography: Behtash Bahador is an Associate Director at the non-profit organization CISCRP, and holds a Master of Science in Health Communication from the Tufts University School of Medicine. Since 2014, he has collaborated with a range of stakeholder groups to establish and implement patient- and public-centric initiatives across the life-cycle of drug and treatment development. This has included supporting the development of regulatory and cross-disciplinary best practice guidelines, operationalizing key elements of evidence-based public health programing into research engagement activities, and always keeping the needs of patients, participants and the public at the forefront of his work.
Session Details: This is Not a Trend: Exploring Why Patient-Centered Clinical Research Will Continue to Change the Research Paradigms of the Past and the Impact it Can Have 25-05-2021, 1:45 pm View In Agenda
Head of Clinical Operations,Click Therapeutics
Former Associate Vice President, Global Clinical Trial Management at Allergan
Former Executive Director, Global Clinical Trial Management at Actavis plc
Former Executive Director, Clinical Operations at Warner Chilcott
Former Senior Director, Technical Services at Consumer Product Testing Company
Former Section Head, Toxicology at Leberco Testing
A., Biology, Rutgers University
Session Details: CASE STUDY - Exploring the Use of Technology When Moving Towards a More Patient-Centric Trial 25-05-2021, 4:00 pm View In Agenda
Digital Strategy Lead, Clinical Trial Innovation,Novartis
Biography: Sameer is a senior executive with over 24 years of both pharma/CRO experience in operations, feasibility, site selection, business development, procurement, strategic planning, and project management. Recent roles have focused on innovative approaches to support digital solutions integrated in our clinical trials to reduce patient burden and maximize efficiency in site selection and patient recruitment.
Session Details: Decentralized Trials: Managing the Moving Parts to Result in a Successful Trial 25-05-2021, 1:45 pm View In Agenda
Director of Clinical Outsourcing,Otsuka
Biography: Ratan Ratnesh is a Director and Head of Clinical Outsourcing at Otsuka Pharmaceutical. He received his Bachelors in Mechanical Engineering from National Institute of Technology, India and an MBA from University of Louisiana. Ratan has broad experience in strategic sourcing, clinical outsourcing, operations and supply chain improvements in Fortune 500 and growth companies. He started his career in management consulting specializing in supply-chain across different industries and moved to clinical outsourcing in early 2000. In Pharmaceutical industry he worked at Wyeth and Novartis prior to joining Otsuka and he has managed different categories related to clinical outsourcing.
Session Details: DEBATE SESSION - Exploring What We Need to Know When Choosing the Right CRO for your Trial 25-05-2021, 10:00 am View In Agenda
Associate Director, Relationship Manager,Merck
Biography: Pharmaceutical professional with over 20 years of experience in clinical research, operations, outsourcing and vendor relationship management. Diverse experience in multiple therapeutic areas and various clinical trial phases. Experience leading large cross functional teams and developing supplier governance models. Associate Director at Merck & Co., Inc. in the Portfolio Sourcing and Relationship Management group within Global Clinical Trial Operations. Currently manages Strategic Functional Service Providers within eight Clinical Development Business Units (areas have included Statistics, Regulatory, Data Management, Global Clinical Monitoring, Clinical Sciences, Medical Writing and Clinical Trial Operations). Began my career as a Study Coordinator for the Cardiovascular Disease Prevention Center at Thomas Jefferson University Hospital, Philadelphia, PA. Earned a Masters of Public Health from DREXEL UNIVERSITY COLLEGE OF MEDICINE (formerly MCP HAHNEMANN UNIVERSITY), Philadelphia, PA and a duel Bachelor's degree from Villanova University.
Kristine Koontz
Head of US Clinical Operations,GlaxoSmithKline
Biography: Kristi Koontz is currently the Head of US Clinical Operations for GSK. Prior to this, she has held a variety of roles across clinical development and global medical affairs. Kristi has established numerous oncology corporate and academic and alliance partnerships, life cycle strategies, external engagement initiatives, and advocacy partnerships. She holds a BS in Biology from The Pennsylvania State University, an MBA from LaSalle University, and is finishing her PhD in Business Psychology from The Chicago School.
Session Details: GSK KEYNOTE - Exploring How Best to Manage a Shifting Portfolio 25-05-2021, 9:00 am View In Agenda
Pam Duffy
Director, Digital & Technology, Pfizer,
Session Details: Pfizer KEYNOTE: A Fresh Look at Patient Recruitment Focusing on the Top of the Funnel – Is Our Image the Problem? 25-05-2021, 3:00 pm View In Agenda
Kathy Leach
Senior Director of Clinical Operations,Pfizer
Biography: Kathy Leach is Senior Director, Clinical Study Team Lead at Pfizer. She has been in the pharma industry for 25 years, spanning numerous therapeutic areas, phases and roles supporting clinical trial conduct at several large pharmaceutical companies. Her recent roles have focused on cross functional operational oversight of global programs. Kathy is a certified Project Management Professional, received her bachelor degree from Villanova University and Masters in Organization Leadership from Immaculata.
Session Details: PANEL DEBATE - "This House Believes that Larger Pharma Companies have the Better Approach When it Comes to Organizing a Clinical Trial" 26-05-2021, 10:00 am View In Agenda
Frank Leu
CEO, Novapeutics,
Frank Leu is a Co-Founder and CEO of Novapeutics at Philadelphia, PA - a biopharma spun-out from the University of Pennsylvania, developing a first-in-class small molecule beta-cell restoration curative for type 2 diabetes. Prior, Frank was at a specialty pharma Verto Institute, developing biologic therapeutics for treating the neuroendocrine cancer. Frank graduated with a Pharmacology Ph.D. from Weill Cornell Graduate School of Medical Sciences in 2001, and then post-doc in a Howard Hughes Medical Institute laboratory at the Rockefeller University in molecular enzymology. He has served as an adjunct instructor at the Rutgers Cancer Institute of NJ, and is an adjunct professor at the pharmacology department of the Thomas Jefferson Medical University. Frank also founded BioPharMatrix developing blockchain solutions to lifescience innovations at all phases, and serves as advisor to the Pennovations center working with 1776 / Benjamins Desk. Frank is a thought leader in the blockchain architecture innovations in the life-sciences and drug development, Frank serves on multiple advisory boards and frequently served as chairman, speaker, moderator, and facilitator for many life-sciences and drug development events.
Session Details: View In Agenda
Terrence O'Brien Tormey
Former CEO,Kibow Biotech, Inc.
Biography: Tormey has more than 44 years of Sales and Marketing, and Executive experience in the global pharmaceutical market. 2017-2020, Mr. Tormey held the position of Chief Executive Officer at Kibow Biotech, where the company developed product a novel treatment for Chronic Kidney Disease. Prior to Kibow, he was a Member of the Board, and Vice-Chairman of Prevention Pharmaceuticals Inc, where he previously held the position of President/CEO beginning July 2010. From 1985 to 1990, Tormey lead Medical/Hospital/Industrial Sales with Wyeth. From 1990 to 2003, Tormey was with Nelson Communications Worldwide. First, as VP at PDN, and then as President of The Medical Phone Company®, and later as President/COO of Nelson Communication's flagship company, Nelson Professional Sales (later known as Publicis Selling Solutions), Publicis, S.A., Paris. From 1976 to 1985, Mr. Tormey held Sales & Sales Management positions at Ortho Pharmaceuticals, and then as Director of Sales Staff Management with McNeil CPC (Johnson & Johnson).
Session Details: DEBATE SESSION - Exploring What We Need to Know When Choosing the Right CRO for your Trial 25-05-2021, 10:00 am PANEL DISCUSSION - Studying the Importance of Getting A Diverse Patient Group Onto Your Study 25-05-2021, 4:00 pm View In Agenda
Timothy Koch
Global Head Key Account Management – Trial Management, Transformative Business Operations within GDO,Novartis
Tim Koch has spent the last 18 years working in Big Pharma including time at Johnson & Johnson, GlaxoSmithKline, and currently Novartis, along with prior experience in the Financial Services Industry and the Hospital Setting. He is a Lean Six Sigma Black Belt who's deepest passion is Metrics and Analytics but has a broad range of experience from Finance to IT to Quality Assurance to Resource & Risk Management. He is known as a domain expert in Clinical Trial Optimization via Data and Technology, supporting the operational delivery of thousands of Trials from feasibility/site selection to recruitment planning/tracking to instream monitoring, resource maximization and risk detection to leading health authority inspections. Tim has been an innovative pioneer, infusing an evidence-based analytical culture in countless areas of the business, building multiple Analytics units from the ground up and launching >50 industry-first analytics platforms to >20,000 users in Drug Development. In his current role as Global Head of Key Account Mgmt, he partners closely with the Trial Mgmt Leadership team providing consultation, solutions and know-how anchored around the use of data, analytics, processes and technology during Trial Delivery.
Session Details: Chairperson's Opening Remarks 26-05-2021, 8:50 am Speaker Hosted Roundtables 26-05-2021, 3:30 pm View In Agenda
Michael Child
Vice President Clinical Operations,Arbutus Biopharma
Biography: Mike Child currently holds the position of Vice President, Clinical Operations at Arbutus Biopharma located In Warminster PA, near Philadelphia. Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). Prior to that, Mike spent approximately 31 years at Bristol-Myers Squibb (BMS) near Princeton, NJ where he attained the role of Director, Clinical Operations, Infectious Disease contributing to the global approval of novel therapies designed to treat HIV and Hepatitis C. In addition, while at BMS, Mike spent significant time learning the ways of Drug Development while working in Discovery Labs, in the Data Management Department, and finally in roles of increasing responsibility within Early Development/Clinical Pharmacology. Mike's additional experience includes that related to due diligence and risk mitigation, outsourcing, model document management, and the maintenance of Standards and Processes. Mike graduated with a BS in Animal Production from The Pennsylvania State University (PSU) and completed graduate coursework in Physiology before leaving PSU for Squibb. Mike was born in Lancaster, PA and currently lives in Newtown, PA where he has raised 2 sons.
Session Details: Ensuring Top Quality Project Teams from Vendors from a Small Biotech's Point of View 26-05-2021, 2:30 pm View In Agenda
Gregory Bergonio
Executive Director, US Clinical Operations,Klus Pharma
Jeremy Cress
Director, Operations,Fibrocell Science
Biography: Jeremy Cress, Director of Operations of Fibrocell Science, has 15 years of experience in the biotech/pharmaceutical industry developing and leading solutions-based strategies across all phases of drug development through commercialization, including global manufacturing and distribution. His management experience at Fibrocell is highlighted with the manufacture and commercial scale-up of the first approved cell therapy for aesthetics, LAVIV® azficel-T. Today, Mr. Cress and his team are working in collaboration with Precigen, Inc., a wholly owned subsidiary of Intrexon Corporation, to advance development of Fibrocell's gene therapy candidates for the treatment of rare diseases affecting the skin and connective tissue. Currently, the team is focused on FCX-007, the Company's lead candidate for the treatment of recessive dystrophic epidermolysis bullosa (RDEB)—a devastating, congenital, blistering skin disease with high mortality. Prior to joining Fibrocell in 2011, Mr. Cress was Director of Operations for Fisher Clinical Services where he had responsibility for manufacturing, domestic and international logistics, and distribution and supply chain activities for >30 pharmaceutical companies and >100 clinical trials.
Session Details: Bringing a Small Supplier into your Trial: Exploring How to Work With a Niche Supplier 26-05-2021, 11:15 am View In Agenda
Madeline Geday
Director, Global Patient Innovation & Engagement,Merck
Biography: Madeline is Director of Global Patient Engagement and Innovation within the Global Clinical Trial Operations group at Merck and Co., Inc. She spearheads the Patient Engagement and advocacy efforts for her organization. In this role, she is responsible for optimizing clinical trial feasibility and execution through integrated data-driven expert analysis and recommendations, while promoting its engagement, development, and opportunities for innovation in recruitment and retention. With a keen focus on the perspective of the patient, she is intent on capturing and integrating the voice of the patient into operational aspects of clinical trial design, feasibility and recruitment and retention. She also works on several collaborative projects surrounding Diversity in Clinical Trials. Her efforts are targeted at creating awareness and education for the need for diversity and inclusion and in late stage drug development. Trained in Health Literacy principles, she has used her knowledge and expertise to champion changes to patient facing materials to ensure health literacy for clinical trial participants, caregivers, and their families around the world. Madeline joined Merck in 2004. She began her work as a Medical Program Clinical Specialist working on several insomnia programs in clinical neuroscience with a focus on patient recruitment and retention. Madeline joined Global Trial Optimization in 2006 where she has spearheaded hundreds of patient recruitment initiatives, served as Therapeutic Area lead for Neuroscience, Ophthalmology, Hematology and Multiple Myeloma as well as Process Owner and Subject Matter Expert for the department. While at Merck, she has helped launch the Clinical Trials Microsite of merck.com; has led multiple voice of the patient projects; and has served as an industry expert in the field of patient engagement, recruitment and retention and heath literacy. Prior to Merck, Madeline held positions in Business Development, Education, and in Clinical Research as a CRA. Madeline received a dual B.S. degree in Psychology and Exercise Physiology from Ursinus College in Collegeville, Pennsylvania and is pursuing graduate coursework in Marketing from Temple University.
Colleen Kostic
Associate Director, Outsourcing Management,Bristol-Myers Squibb
Colleen is a pharmaceutical industry leader experienced in building, changing, and growing teams into highly successful organizations
Session Details: Getting Inspection Ready – Taking Steps now to Ensure you Comply to International Guidelines 26-05-2021, 9:00 am View In Agenda
Brandon Maggio
Associate Director,Boehringer Ingelheim
Biography: I have worked in the industry for 15+ years, and joined Boehringer Ingelheim in 2011. During my tenure at BI, I managed multiple pivotal Phase 3 trials within the Metabolic, CNS, Cardiovascular, and Respiratory therapeutic areas. In 2018, I took on the role of Global Clinical Operations Integration Lead for Decentralized Clinical Trials. This position coordinates with all other supporting trial enabling functions, as well as, facilitation of educational and change management activities for BI's clinical research ecosystem.
Session Details: Patient Centricity through Decentralized Clinical Trials and Telemedicine 25-05-2021, 3:00 pm View In Agenda
Alice Drumheller
Vice President of Clinical Operations,Sensei Bio
Biography: Alice Drumheller has over twenty years' experience in the clinical operations area with the focus on executing clinical trials. Prior to joining the Sensei Bio, Alice was Senior Director of Clinical Operations at MacroGenics where she executed the company's clinical strategy. Previous to MacroGenics, Alice was part of the team at Amgen/Micomet where she contributed to the approval of BLINCYTO®. Alice has held positions of increasing responsibility at large pharmaceutical companies, start-up companies and clinical research organizations, including Nabi Biopharmaceuticals, Bristol-Myers Squibb, Kendle (now Syneos), British Biotech and Henri Beaufour Institute (a subsidiary of Ipsen). Alice holds a BS in Public and Community Health from Southern Connecticut State University in New Haven, CT.
Session Details: THINK TANK - A Group Exercise Focused on Working with Colleagues to Find Solutions to Stumbling Blocks that can Arise During your Trial 25-05-2021, 4:30 pm Speaker Hosted Roundtables 26-05-2021, 3:30 pm View In Agenda
Anna Chepushtanova
Global Innovation Specialist,Nestle Waters
Kristina Dabovic
Director of Clinical Operations,mTem
Biography: Kristina has excellent interpersonal, verbal and written communication skills; A flexible attitude with respect to work assignments and new learning; Ability to manage multiple and varied tasks with enthusiasm and prioritize workload with attention to detail; Ability to identify and address issues proactively in a timely manner and willingness to work in a matrix environment and to value the importance of teamwork. She also possesses team leadership skills and excellent organizational ability.
Session Details: CASE STUDY - CRO Relationship Management: Working Through Issues with your CRO to Stay in Control of Your Study 26-05-2021, 12:15 pm View In Agenda
Sudip Gangopadhyay
Head of Clinical Digital Solutions,Immunomedics
Biography: Sudip is a performance driven executive with 25+ years of global experience in delivering business value through R&D Digital Technology management. His roles have had progressive scope, complexity and authority for planning and execution of strategic business and technical delivery. He is a proven leader with multi-sector international experience in building organizations, establishing business relationships, developing high performance teams, and innovative clinical digital solutions & services to enable science in accelerating delivery of the drug pipeline. Sudip's specialties include: Significant experience in the global Pharmaceutical and Information Technology industry in a variety of strategic senior management roles. He has a proven ability to lead major change initiatives and transform R&D technology and Clinical Digital Solutions organizations. He has also effectively developed relationships with key business partners and managed diverse stakeholder interests.
Session Details: Moving to An Electronic TMF and The Benefits it can Bring 25-05-2021, 12:15 pm View In Agenda
Karrie A Hilsinger
Clinical Program Study Director,Immunomedics
Biography: Karrie Hilsinger is Director, Clinical Operations at Immunomedics. She has been in the pharma industry for 20+ years, spanning numerous therapeutic areas, phases and roles supporting clinical trial conduct at several large pharmaceutical companies, CROs and Medical Device organizations. Her recent roles have focused on cross functional operational oversight of global programs. Karrie has been crucial to leading organization through SOP development, Inspection readiness and successful agency inspections.
Adam Barrows
Clinical Trial Lead & Study Director,Bristol Myers Squibb
Biography: Adam Barrows is a Clinical Trial Lead/Study Director for Bristol-Myers Squibb working in Oncology Clinical Development working on Immuno-Oncology agents in the Emerging Tumors team. Adam started his career in clinical research working for ICON Clinical Research in data management and study start-up. Following his time at ICON, he worked in clinical pharmacology at Wyeth then trial operations at Merck. Having spent the majority of his clinical research profession in clinical operations Adam has shifted his focus to strategic trial design and execution as part of the clinical development team at BMS. As a passionate researcher, Adam has worked across multiple therapeutic areas in every phase of clinical research, from start-up to study closeout and brings his operational skills to the scientific execution of clinical trials.
Session Details: Bristol Myers Squibb Insights Sharing Session: Streamlining the Flow of Information to Address the Hypothesis and Futureproof Data 26-05-2021, 12:15 pm View In Agenda
Nimit Jain
Head of Data Science,ACOE at Novartis
Session Details: Novartis Led - Ask the Expert: Building a Data Science Team for Medium – Large Enterprise: Key models to consider 26-05-2021, 11:15 am View In Agenda
Narayan Lebaka
Director of Clinical Data Management,Rgenix
Biography: Narayan has and ten (10)+ years of award-winning and progressive experience delivering the highest standards of clinical data management at Bayer and Bristol Myers Squibb (BMS). Bayer Gold Award 2017, Bronze Award 2016, and Pinnacle Award 2015; BMS Performance Award. In-depth knowledge of all aspects of clinical data management, reporting, reconciliation, study reviews, and standards development that drive pharmaceutical businesses forward.
Session Details: Exploring how data managers should be analysing data in order to achieve high-quality, statistically accurate findings 26-05-2021, 9:30 am View In Agenda
Terry Katz
Director of Global Data Management and Statistics,Merck Animal Health
Biography: Terry Katz is Director, Head of Global Data Management and Statistics for the Animal Health Division of US-based Merck & Co (known as MSD outside of the USA & Canada). Previously, he was VP, Biometrics, at ImClone Systems (human oncology) and a statistical manager at PRA International and Schering-Plough. He earned a BS in Microbiology, MS in Statistics, and post-MS certificate in Management Information Systems. Terry is a Certified Quality Engineer, a Certified Six-Sigma Green Belt, an Accredited Professional Statistician, a 2018 MSD Fellow for Global Health (human oncology project in Kenya) and is the current Chair, DIA's Good Clinical Practices – Quality Assurance Community.
Session Details: Solving the Dilemma with Merck: Simplifying the Route to ICH E6 (R2) Compliance: harnessing the benefits of the various RBM tools at your disposal 26-05-2021, 9:00 am The Big Debate: The Time, Money and Quality Triangle - is it possible to achieve all three with the coupling of eData management and manual data systems? 26-05-2021, 10:00 am View In Agenda
Mirriam Limage-Pierre
Director of Clinical Data Management, Shionogi,
Biography: With over 15 years of extensive clinical-trial experience, Mirriam has extensive working knowledge of data management and GCP and ICH guidelines. As such, I oversee the activities of direct reports and serve as a mentor. I am also responsible for creating the CRF design and ensuring that all protocol required assessments are being collected and the database is built according to specifications. Specialities include; mentoring, leadership and coaching skills, matrix organization, project management skills, GCP/ICH guidelines, CRF Design, DB development, tables and listings, validations, derivations, database testing, SAE reconciliation, discrepancy management
Session Details: The Big Debate: The Time, Money and Quality Triangle - is it possible to achieve all three with the coupling of eData management and manual data systems? 26-05-2021, 10:00 am View In Agenda
Phi Tat
Central Monitor Manager,Pfizer
Biography: Phi is currently working as currently working as a Central Monitor (Manager) at Pfizer in the Risk-Based Monitoring (RBM) team to monitor and identify risks associated with conducting clinical trials and the quality/integrity of clinical data. Responsible for timely and high quality risk-based monitoring (RBM) analytics to clinical trial monitoring which utilizes data and site level information to determine needs for performing on-site, remote, and centralized activities and focuses resources on risks that have the most potential to impact patients' safety and data quality.
Session Details: The Big Debate: The Time, Money and Quality Triangle - is it possible to achieve all three with the coupling of eData management and manual data systems? 26-05-2021, 10:00 am Speaker Hosted Roundtables 26-05-2021, 3:30 pm View In Agenda
Lisa Squibb
Senior Associate Director Data Management,Boehringer Ingelheim
Biography: Lisa has been in data management in the pharmaceutical industry for almost 30 years. Prior to working for Boehringer-Ingelheim, Lisa has worked at Bristol-Myers Squibb and Purdue Pharma. She has been involved in several projects under multiple therapeutic areas including immunology, neuroscience, sexual medicine, diabetes and cardiovascular health, and pain management. Lisa holds a Ph.D. in Health Psychology, a Master's of Public Health and a Master's of Business Administration in the area of International Business. Lisa is also a volunteer certified Emergency Medical Technician in her local town of Monroe, CT and has been involved in emergency services for nearly 15 years.
Alyce King
Senior Business Development Manager,Novotech
Biography: Business Development professional with 10+ years experience working in Healthcare and Clinical Research. Established track record of closing complex multimillion dollar deals. Skilled in strategic relationship development, clinical research, prospecting, development of proposals, budgets and presentations, as well as contract negotiation and management. Strong communication, leadership and analytical skills with a BS in Chemistry and Human Physiology from Monash University. Currently working for Novotech - a rapidly growing, fast paced, full service CRO, covering the Asia Pacific region.
Session Details: Accelerating Clinical Trials in the Asia Pacific Region 25-05-2021, 9:30 am View In Agenda
Kelly Ragins
Vice President, Global Clinical Trial Strategy & Operations,Bristol-Myers Squibb
Biography: Kelly Ragins joined Bristol-Myers Squibb as Vice President of Clinical Trial Strategy and Operations in February of 2018. In this role, she led program and trial management across the portfolio. With the integration, Kelly will focus on the late development activities including non-registrational, investigator sponsored, and medical affairs trials as a member of the Global Development Operations leadership team. With over 25 years R&D experience with concentration on strategic roles, Kelly has developed expertise in the implementation of departments, effective alliance management, and cross-functional collaboration. Prior to joining BMS, Kelly served as Vice President of Internal Medicine Clinical Strategy at Syneos Health. For many years, she was a leader in the Pfizer Global R&D organization within Oncology operations, and as head of Study Management for Vaccines at Pfizer she co-led the Wyeth portfolio integration. Over her career, Kelly held leadership positions at Amgen in the Global Development organization establishing Clinical Operations Management group. She worked for many years within the Clinical Development & Medical Affairs organization at Merck, and conducted pre-clinical research at the Mayo Clinic. Kelly has a pre-med Bachelor's degree in Anthropology and Spanish, and a Master's degree in Healthcare Leadership.
Justin Albani
Director, Imaging Services,Invicro
Biography: Justin Albani is the Director of Imaging Services at Invicro, an imaging solutions provider specializing in the application of imaging biomarkers in drug development and clinical research. Justin has over ten years of experience in clinical research and medical imaging, where he focused on imaging operations and data collection, review, and standardization. At Invicro, Justin is responsible for the oversight of global training and imaging equipment qualification across center's participating in Phase I -III clinical trials, as well as imaging data receipt and processing.
Session Details: Obtaining High Quality Imaging Data from Clinical Trials 26-05-2021, 9:30 am View In Agenda
Michelle Marlborough
Chief Product Officer, Product Management,AiCure
Biography: As Chief Product Officer at AiCure, Michelle Marlborough is responsible for the product direction, definition and delivery of the company's award-winning artificial intelligence platform. With over 24 years of experience in life sciences and software development, Michelle has been at the forefront of transforming clinical trials through innovative technology and analytics and previously held the positions of Vice President of Product Management at Veeva and Vice President of Product Strategy at Medidata Solutions. Before making the shift to the technology sector, Michelle worked in data management roles at GlaxoSmithKline and AstraZeneca. There she experienced firsthand the industry's struggle with outdated processes and systems. Michelle earned her bachelors of science degree in biology and mathematics from Coventry University.
Session Details: Accessing Meaningful Subject Data and Clinical Insights Throughout the Clinical Trial Process 25-05-2021, 11:45 am View In Agenda
Madhu Kumar Komuravelli
Data Management Site Head - Associate Director CDM,Regeneron Pharmaceuticals
Worked in the Pharmaceutical/Biotech/CRO industry since last 23 years with more than 20 years of experience in the Clinical Data Management area on both Sponsor & CRO Side. Successfully led multi-faceted data management project teams to globalize clinical data management processes, systems & organizations and currently working at Regeneron Pharmaceuticals as the Data Management Site Head (Basking Ridge, NJ)/ Associate Director, CDM. Handled and supported several Clinical Studies (Phase 1 to Phase 4) across various therapeutic areas like Immunology, Oncology, CV, CNS, & Rare diseases. Completely familiar with technology and its role in the Clinical Data Management space and performed/supported several technology related initiatives.
Bill Cooney
CEO,MedPoint Digital
Bill Cooney founded MedPoint Digital in 1990. As President and CEO, he continues to lead the strategic growth of a world-class digital services company to the medical industry. Prior to launching MedPoint, Bill was on the Executive Committee and helped start-up Discovery International, the medical education arm of Publicis Healthcare.
In the 1980s, Bill worked in sales and marketing positions at Wyeth and Abbott. He was Business Unit Manager for the Depakote brand at Abbott, and helped form the first telemarketing sales department at Abbott.
Throughout his career, Bill has spoken at numerous healthcare industry events and bylined articles in pharmaceutical trade journals on topics ranging from medical education to research training and digital technology. Bill is Chairman of the Board of Directors for Healthcare Consultants International, Inc., a company providing training and consulting services to healthcare providers and facilities. Bill holds an M.B.A. from the Fisher College of Business of The Ohio State University and a B.A. from The University of Virginia.
Session Details: Digital Document Ecosystem 26-05-2021, 2:00 pm View In Agenda
Dennis Salotti, MS, MBA, CCRA
Chief Operating Officer,The Avoca Group
Biography: Dennis is a life sciences executive bringing over 18 years of experience in Clinical Research, Technology, and Operations. Offering broad achievements in the Pharmaceutical industry in clinical operations, portfolio management, vendor qualification, relationship management and eClinical solutions. He possesses focused leadership skills to drive results in highly competitive markets.
Session Details: Current State and Future Vision of Vendor Qualification and Oversight 25-05-2021, 2:30 pm View In Agenda
Jorge Franceschi
Director, Clinical Business Development,TrialCard
Biography: Since 2002 Jorge has been involved in pharmaceutical, biotech, and biologics research in a variety of roles including clinical, operations, finance, market Intelligence and business development at the site level, SMO, CRO, and now for clinical supply solutions and access at TrialCard. Past employment includes Sarkis Clinical Trials, Radiant Research, Covance, Interventional Concepts, MedPrimo Research as an independent consultant, FutureLife LLC advisory board member, and the University of Florida/VAMC Department of Neurology. Cumulatively he has been involved in over 350 clinical trials including Phase I-IV, PK/PD, vaccine, 510k submission, vaccine research, and has conducted both pediatric and adult trials. Mr. Franceschi completed his undergraduate work at the University of Florida in Food Science & Human Nutrition and completed his Masters of Science in Health with emphasis in nutrition at the University of North Florida in Jacksonville. A majority of his clinical trial work has been within the CNS realm supporting major depressive disorder, anxiety, bipolar, ADHD, and PTSD research but most recently he is learning about and supporting clinical teams needing oncolytic co-therapy medications.
Session Details: Proven Technology Driven Clinical Trial Supply Alternative 25-05-2021, 2:30 pm View In Agenda
Novotech is an Australia based clinical CRO operating across Asia and South Africa. Headquartered in Sydney since 1996, Novotech has come to be recognised as the CRO of choice for many US and European biotechnology firms in the Asia Pacific. Our full service offering includes clinical program management, biometrics services and regulatory affairs.
The Avoca Group is a life science consulting firm dedicated to improving quality and compliance in clinical trial execution. Since 2011, the Avoca Quality Consortium®, a collaborative of over 100 pharma, biotech, CRO, and clinical service provider companies, has led the industry in developing practical solutions for improving quality and execution in clinical trials.
With over 40 years' experience, 600 beds and locations in NA, EU and Asia, Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and NDA-enabling clinical pharmacology research. Celerion provides full study services including statistics, data management and biostatistics (including PK/PD analysis), and bioanalytical services.
We are the quantitative imaging experts working across the entire drug development spectrum to better diagnose, characterize, treat and cure disease. Invicro is leading innovation to elucidate biological processes for our pharmaceutical and biotechnology partners around the world. www.invicro.com
MedPoint Digital develops intuitive, ICH-GCP compliant eClinical platforms for virtual investigator meetings, trial portals, interactive modules, and virtual clinical trials. Our digital solutions enable sites to be more productive, with online study training, study eBinders (eISF), digital study alerts and SUSARs, patient visit guides, and a wide range of study tools, available via web portals and mobile apps.
Founded in 2015 Teckro provides solutions to simplify and modernize clinical research for leading pharmaceutical and emerging biotech companies. To date, Teckro manages more than 100 clinical trials and is used by more than 11,800 active study sites around the world. Teckro employs more than 100 staff across its global headquarters in Limerick, Ireland, engineering excellence hub in Dublin, Ireland and its US-based office in Nashville, Tennessee. Visit www.teckro.com for more information.
TrialCard provides solutions for Patient Access, Prescription Abandonment, Hub/Reimbursement, Analytics, and Clinical Trial Support.
KPS is a global, innovative, Clinical Outsourcing Provider delivering clinical trial monitoring, management and quality oversight services to pharmaceutical, biotechnology, medical device, and related industries. Founded and operated as a more customer centric and nimblealternative to traditional CROs, KPS offers a full range of services leveraging the latest clinical technologies.
4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. 4G Clinical is headquartered in the Boston Biotech corridor of Wellesley, MA, with offices in Europe and Asia. For more information, please visit www.4gclinical.com
ACM Global Laboratories is one of the largest global independent central labs in the industry. ACM is certified by the College of American Pathologists (CAP) and the Substance Abuse and Mental Health Services Administration (SAMHSA). The company delivers high-quality laboratory testing and diagnostic lab services in support of both clinical trials research, toxicology and individual patient care. ACM provides a powerful combination of operational excellence, scientific expertise and unsurpassed global service to customers in more than 65 countries. ACM performs more than 20 million laboratory tests each year—spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more.
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture. The international company is a privately owned organisation which has grown organically over the past five decades now employing over 5,600 highly skilled personnel across 18 facilities including Europe, the US and Asia. The company has a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients. To keep up to date with latest news, follow Almac Group on Twitter and LinkedIn or visit almacgroup.com.
Avantor provide Global Equipment Solutions to the Clinical Trials industry. Currently Avantor supports clinical studies running in over 70 countries taking care of all aspects of the medical equipment and related products on your clinical studies from initial enquiry through to end of study removal
Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: DM, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs.
As the research division of BioTelemetry (Nasdaq: BEAT), we provide one of the world's largest clinical data networks. BioTelemetry Research's broad range of Cardiac and Imaging services support both safety assessments and efficacy evaluations across all major therapeutic areas, through all phases of clinical trials, in every global region.
Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With our global footprint and access to leading regional labs, data, patients, technology, and partnered resources, we support global biotech, pharma, and IVD organizations to improve the lives of patients around the world.
Clinical Solutions Group is centered around biopharma solutions with a 19-year track record of delivering high-quality consulting and service offerings to top-tier drug development companies.
Clinipace is a global, full-service CRO with a CHALLENGE ACCEPTED approach. We are collaborative and flexible, and provide personalized services and solutions, local regulatory expertise, and therapeutic leadership for your drug discovery projects.
DP Clinical is a full-service CRO specializing in flexible, high-quality solutions for the most complex clinical trials. For 25 years, DP Clinical has worked in all major therapeutic areas with significant experience in infectious disease, neuroscience, oncology, and ophthalmology programs. To learn more about us, visit www.dpclinical.com.
DSG, Inc. celebrates over 25 years as a leading global eClinical provider with a fully integrated suite of innovative technology solutions and data management services: Award-winning eCaseLink™ EDC & DSG Designer for Enterprise licensing with CDISC standards; Risk-Based Monitoring, eSource, IWRS Randomization and Clinical Supply, Drug Safety, Patient Profiles, ePRO, CTMS, Site Payment, Protocol Violations, ad-hoc reporting, CDM services, and digital on-demand Clinical Printing services.
Founded in 1986 by Alois Bischof, ELPRO is a Swiss-based, global manufacturer of innovative environmental monitoring solutions for the pharmaceutical, life science, biotech and health care industries. ELPRO does not only offer state-of-the-art data loggers but also complex monitoring systems with intelligent database solutions, and overall GxP support. Automatically generated PDFs and high data security guarantee that customers worldwide can always stay compliant. ELPRO's data loggers measure temperatures from -200 °C..+200 °C. ELPRO's sales and technical support offices are located in Switzerland, US, Canada, UK, Germany, the Nordics, Benelux and Singapore, with 220 employees worldwide.
ERT is a global data and technology company that minimizes risk in clinical trials, helping sponsors bring treatments to patients quickly, with confidence. ERT's solutions have supported half of FDA new product approvals since 2013 by enhancing trial oversight, enabling site optimization, increasing patient engagement, and measuring treatment efficacy while ensuring patient safety.
Eurofins BioPharma Services provides seamless, end-to-end solutions to help clients progress through the drug development cycle through a single, experienced provider. Our integrated solutions deliver the most comprehensive range of state-of-the-art analytical technologies with an expansive geographic reach in order to globally support our clients' clinical testing needs.
Celebrating our 25th anniversary in 2020, FMD K&L is a global Contract Research Organization supporting Data Management, Biostatistics, Statistical Programming, Clinical Operations, Regulatory Affairs, Safety, Pharmacovigilance, Toxicology, Medical Affairs, Medical Writing, Quality, Risk, and Compliance services to the Pharmaceutical, Biotechnology, and Medical Device industries worldwide.
Greenphire is the industry leader of clinical payment technology, designed to improve the way research professionals work. We leverage our proprietary payments platform and workflow automation to help clients improve operational efficiency, reduce costs, mitigate regulatory risks, improve the patient and site experience and produce quantifiable results that improve clinical operations and strategic planning.
Harbor Clinical, a WBENC-certified, women-owned company, provides a hybrid of services which ensure all aspects of clinical trials meet quality assurance and regulatory standards – from study documentation, vendor oversight, and flexible resourcing throughout operations. Developing and supporting your quality initiatives from Day 1, the Harbor team is committed to quality through each functional service we provide.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We are a global provider of outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas. ICON has been recognised as one of the world's leading Contract Research Organisations through a number of high-profile industry awards.
IDDI optimizes the clinical development of drugs, biomarkers and IVD using a unique combination of advanced biostatistics and innovative data collection technology. IDDI covers the full spectrum of trial design, clinical data collection, management, analysis and reporting for Phase I- IV clinical trials. - IDDI's services include: Clinical Development Plans, Protocol Development, Randomization (IWRS/IRT) with Drug Supply Management, EDC, Medical Coding, Data Management, Biostatistics, IDMC Support, Biomarker/Diagnostics Validation, Medical Writing. - IDDI's therapeutic areas of expertise include oncology, ophthalmology, infectious diseases and cardiology. - Experience: 27+ years - 980+ trials (630+ in oncology) - 20 FDA/EMA approvals to-date - HQ in Belgium with offices in the USA ( Raleigh, NC, Boston, MA and San Francisco, CA).
International Dermatology Research, Inc. is a research Site specializing in dermatology and women's health. Headquartered in Miami, FL it provides state-of-the-art facilities, highly qualified staff and 9 additional sites in Latin America. Over the past 20 years IDR has gained excellent recognition for conducting successful Phase II – IV studies.
LabConnect provides global central laboratory services including routine and esoteric lab testing, kit building, sample management, biostorage and scientific support services for our biopharmaceutical clients. LabConnect's unique combination of state-of-the-art technology, world-class laboratories, easy access to emerging markets and extensive specialized testing expertise means the drug development industry can rely on a single provider for all of their central lab needs.
Longboat is a clinical technology solution for study teams, monitors, and site staff. Designed to help clinical trial staff to manage and track trials from start to end, Longboat provides tools for patient recruitment, consent, training site staff, monitoring engagement and performance, patient-specific walkthroughs, 21CFR Part11 communication tracking, and more.
Myonex is a global leader in sourcing, distribution, and management of commercial drugs and ancillary supplies for clinical trials and biosimilar research. Our expertise and obsession with ensuring efficient and effective trials are why pharmaceutical and biotech companies, CROs, and clinical packagers worldwide rely on Myonex for their supply needs.
From strategy to operations, N-SIDE offers software solutions and consulting services using state-of-the-art optimization and advanced analytics technologies. Our solution CT-FAST helps you design your optimal clinical supply strategy. Get the right drug to the right place at the right time and at the lowest cost while managing risk.
Nucleus Network is Australia's largest Phase 1 clinical research organisation and the only Phase 1 specialist globally with phase I facilities in the US and Australia. Our Australian phase I facilities are in Melbourne and Brisbane, and our US phase I facility is located in Minneapolis. Combined, our clinics offer over 200 beds. All three clinics are strategically co-located within leading medical, research and biotech precincts offering unique access to ancillary services including bioanalytical laboratories, MRI, lumbar punctures, chest X-rays, ophthalmology assessments and others. Since our establishment in 2004, we have conducted over 700 phase I clinical trials, with 80% of our clients consisting of US based biotech and pharmaceutical companies. We have access to a population of over 10.5 million people across all 3 sites, and the ability to offer a multi-site solution in recruiting participants and patients to our clients. Together with our client partners, we are fulfilling our purpose of 'Advancing medicine, improving lives.'
Oracle Health Sciences
Oracle is a leading strategic software solutions provider to the health sciences industry, helping pharmaceutical, biotechnology, medical device, and healthcare organizations become the most successful in the world by offering the most innovative products and services that deliver the most compelling customer and shareholder value. Oracle's comprehensive industry solutions include clinical trial management and analysis, electronic data capture, adverse event reporting and pharmacovigilance, and healthcare interoperability. Oracle partners with health sciences industry leaders – including 20 of the top 20 life sciences companies and 14 of the top 14 Fortune Global 500 healthcare organizations – to prevent and cure disease, enhance quality of life, and accelerate insights for better health.
PCI Pharma Services is an integrated full service provider, a proven and trusted partner to leading companies in the global healthcare industry. We offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialization, delivering speed-to-market and commercial success for our customers.
PCM TRIALS screens, hires, trains and manages all of our own Certified Mobile Research Nurses who conduct clinical trial visits in the subject's homes. Each nurse is trained, tested, and certified as a Certified Mobile on an annual basis in the principles of clinical trial research, GCP, Nurse Guidelines and IATA. Services are available in U.S., Canada and ROW.
Phase Clinical Services is a full service CRO focusing on Phase 0-II oncology clinical trials. Exclusive overseas access to 51,000 oncology patients per year, close collaboration with top government officials and effective local teams ensure successful trial completion. Exceptionally competitive rates and clinical trial management from New York City.
Peachtree BioResearch Solutions is an Atlanta-based Clinical Research Organization that provides clinical development support services and innovative resourcing solutions to medical device, pharmaceutical, and biotech companies. We are committed to delivering high-quality, cost-effective services according to sponsor timelines and specifications. Flexible. Scalable, Reliable. We're your solution.
Prevail InfoWorks improves the probability of clinical trial success by providing stakeholders real-time actionable intelligence to effectively manage endpoints and key deliverables with the Single Interface™, its patented cloud-based tool that aggregates, reconciles, analyzes and single-view reports/visualizes all clinical, operational and project accounting data, regardless of the source or format.
PSI is a privately-owned, full-service contract research organization (CRO), operating globally. PSI's reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI's global reach supports the operations of clinical trials across multiple countries.
QPS is a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services since 1995. Our mission is to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services. An award-winning leader focused on bioanalytics and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities. We are passionate about our work, creating value for patients and customers while generating opportunities for employees to thrive.
Rho, a contract research organization (CRO) located in Chapel Hill, NC, provides a full range of services across the entire drug development process. For more than 30 years, Rho has been a trusted partner to leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, innovative technologies, and therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience.
SDL is a global leader in content creation, translation, and delivery. Meet us to learn how to achieve the digital transformation necessary to take your content global and deliver upon the promise of Artificial Intelligence and Machine Learning for advancing multilingual content that results in highly optimized operations. SDL leads the industry in reducing costs across the content supply chain and provides the most complete breadth of end-to-end linguistic solutions across the full lifecycle of clinical development, from discovery and product development (Pre-Clinical & Phases I to III), to regulatory submission (EMA/FDA compliance) and commercialization (Phase IV/Sales and Marketing).
SGS is a leading life sciences CRO providing clinical research and bioanalytical testing with a specific focus on early stage development and biometrics. Delivering solutions in Europe and in Americas, SGS offers clinical trial (Phase I to IV) services encompassing full early phase drug development consultancy, clinical project management and monitoring, biometrics, PK/PD modeling & simulation and regulatory & medical affairs services. SGS has its own clinical unit in Belgium including a viral challenge testing facility and two phase I patients units based in Belgium and Hungary. SGS has a wealth of expertise in FIH studies, viral challenge testing, biosimilars and complex PK/PD studies with a high therapeutic focus in Infectious Diseases, Vaccines, and Respiratory.
Signant Health provides solutions that simplify every step of the patient journey to make it easier for people to participate in, and for sites and study teams to run, clinical trials. Signant unites eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry's most comprehensive patient-centric suite – an evolution built on more than 20 years of proven clinical research technology. Our intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable hundreds of sponsors and CROs (including all Top 20 pharma) to extend the reach of drug development, expand patient opportunities and improve data quality – helping them bring life-changing therapies to our families and communities around the world.
Spaulding Clinical Research is a global CRO providing Phase I – IV drug development services to pharmaceutical and biotechnology companies. Spaulding Clinical operates a 200-bed Clinical Pharmacology Unit, a Full Service Biometrics Group and Cardiac Core Laboratory. For more information, please contact us at 262-334-6020, or via email at Daniel.Selness@spauldingclinical.com.
TrialScope gives your clinical trial data superpowers™. The TrialScope Transparency Cloud™ makes centralizing, structuring and activating clinical trial information simple, for use across the organization and at every stage of the study. Our integrated platform is used by 16 of the top 20 clinical trial sponsors in the world, who rely on TrialScope to ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment. To learn more, visit TrialScope.com.
WCCT Global is a multi-site, full service CRO of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. WCCT has extensive experience with healthy volunteer studies including First-in-Human, as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
RPG is a full service, global CRO that originated in 1999. RPG provides project management, site selection and management, safety and medical monitoring, clinical monitoring, data management, biostatistics, and medical writing. Clinical and data teams average >12 years of experience in their respective fields and have worked across all therapeutic areas.
Amazing begins here. EASi is a leading global services company specializing in sciences. For more than 35 years, our team has brought a passion for innovation to deliver critical services and cutting edge solutions. EASi has 3,700 dedicated employees across North America, Europe and Asia.
CISCRP, the Center for Information and Study on Clinical Research Participation, is an independent, nonprofit that has worked globally to understand and improve participant experiences in clinical research for over 17 years. We conduct qualitative and quantitative research, and deliver programming that engages, educates and empowers a wide-range of stakeholders in clinical research. Through outreach and media campaigns we educate the public, patients, medical/research communities, the media, and policy makers about clinical research and the role each party plays in the process. We measure public and patient perceptions of and experiences in clinical research, and collaborate with patients, caregivers, advocates and others to generate input on study protocols, communications, and technologies. And, in order to ensure there is clear, appropriate and empowering information shared with all stakeholders, we develop and deliver research communications for Informed Consent, study results and treatment assignment, sponsor study registries, and educational web portals.
Center for Information & Study on Clinical Research Participation (CISCRP)
OCT East Coast offers solution providers the opportunity to engage with the local clinical trial industry. The event features thought leadership sessions, a wide ranging exhibition, networking opportunities and much more. To enquire about sponsorship opportunities for the conference, please contact our health team at:
Nick McCudden
Head of Sales – OCT East Coast
E: NicholasMcCudden@arena-international.com
The program for the 2021 OCT East Coast has been written in collaboration with the local industry, if you would like to get involved you can contact our team at:
Zoe Mainwaring
T: +44 0207 832 4323
E: zoe.mainwaring@arena-international.com


We are offering an exclusive discount for Chamber members at Emperors Health and Fitness Club based at Middletons Hotel in the centre of York.
Looking for group classes in York? Or maybe you'd like to find a great place to lift free weights? Or maybe you're looking for a place to go spinning in York?
Whether you're looking to kick-start your day with an early morning workout, a fitness enthusiast or athlete, looking to improve your physique, lose weight, join an exercise class with like-minded people, simply relax, or socialise and make new friends, we have the facilities, the equipment, and the expertise to ensure you enjoy ever visit to Emperors and get the most out of your exercise sessions.


How do I establish peace between the Geth and the Quarians?
Can't target anything with the Laser on Rannoch? The following instructions have worked well for me. As a result, you'll need to make wider sprints, corner to corner, giving you less time to fire. With the ship on the move, target the Reaper off to the left of the ship while Shepard calls in for an orbital strike.
The key to surviving this encounter is to know that, counter-intuitively or not, you don't lose your progress if you have to stop aiming and dodge.
Same strategy applies, keep running, stand still, fire for eye. In the next area, your waypoint shows an Override console.
After the opening cutscenes which you can score some Reputation points from , you will touch down on top of a steep slope. Slight clarification.
Sign up for free! Home Questions Tags Users Unanswered.
Destroy the geth fighters on Rannoch before destroying the Reaper base. Cancel Save. Do you like this video? Move to the right of the blast door near the tubes and vault up them.


text:
Websense Finds Cyber-Crime Evidence by Analyzing Network Crash Data
Robert Lemos
A research project aimed at detecting cyber-attacks by analyzing the application crash data has borne fruit.
The technique, which uses the crash dumps created by the Windows operating system, helped unveil a cyber-crime campaign that targeted retailers, researchers from security firm Websense said on Feb. 19.
Using the information created and submitted by Microsoft's Windows Error Reporting tool, also known as "Dr. Watson," researchers at Websense discovered that certain anomalous patterns are signs that an attacker is trying to exploit a vulnerability and inadvertently caused an application to crash, Alex Watson, director of security research at Websense, told eWEEK.
"Instead of trying to identify a specific attack, we look for indicators that could be a sign of attacker activity," Watson said. "When we combine it with other intelligence, we get a picture of a possible campaign."
Application crashes are an all-too-frequent annoyance for computer users and developers alike. Yet security researchers view an application crash as a signal that a vulnerability exists in the software—a vulnerability that could be exploited to compromise the computer system. The technique gained widespread attention when documents leaked from the National Security Agency by former contractor Edward Snowden indicated that intelligence analysts had used the crash reports to identify applications that could potentially be exploited.
After confirming that the technique could be used to identify attack pathways, Websense collected crash reports from point-of-sale applications and created an attack fingerprint from the data. The information, combined with other telemetry, helped pinpoint an attack using Zeus malware at an East Coast retailer that happened over a three-day period, Watson said. Looking more widely, the company identified other retailers exhibiting the same signs of infection.
"When we took all the information together, we saw companies in a single industry, which is the wholesale/retail sector, that were all communicating out to the same command-and-control servers," he said. "So we are likely looking at a new variant of Zeus that is targeting point-of-sale systems."
Websense is not the first company to collect crash data to detect potential attacks on computer systems. Leviathan Security, a security technology and consulting company, has been using a similar technique to detect advanced and targeted malware that would likely escape other detection mechanisms.
Initial Windows error reports are unencrypted and contain information on the applications, services and hardware of a system following a crash. An attacker could use the information to gain insight into a company's environment, while a defender can use the information to find anomalous crashes that may be a sign that an attacker is attempting to exploit a system.
Websense plans to expand the system to gather crash reports from other operating systems and other types of devices. Industrial control systems, such as supervisory control and data acquisition (SCADA) networks, and financial networks would likely benefit from the techniques, Watson said.
Robert Lemos is an award-winning freelance journalist who has covered information security, cybercrime and technology's impact on society for almost two decades. A former research engineer, he's written for Ars Technica, CNET, eWEEK, MIT Technology Review, Threatpost and ZDNet. He won the prestigious Sigma Delta Chi award from the Society of Professional Journalists in 2003 for his coverage of the Blaster worm and its impact, and the SANS Institute's Top Cybersecurity Journalists in 2010 and 2014.